Pharmaceuticals, Biotechnology and Life Sciences
AbbVie plans to it increase its earnings per share and elevates the market value of the remaining shares, as it has authorized a $5 billion increase to AbbVie’s existing stock repurchase program.
AbbVie, the global research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories has declared a quarterly cash dividend of $0.64 per share.
The fourth quarter was a continuation of the strong performance and business momentum AbbVie has delivered since becoming an independent company in 2013.
Janssen-Cilag International NV announced on Tuesday the submission of a Type II variation application to the European Medicines Agency (EMA) seeking…